Analyst Top Biotech Stocks Could Explode After Huge Sell-Off
The Stifel team is focusing on forward updates regarding the status of patent litigation over the 480 mg daily dosing patent covering Tecfidera, and any details on if anti-LINGO data in acute optic neuritis will be presented at a competitor's ...
24/7 Wall St. - Thu, 16 Oct 2014 05:35



Local runner shows nerves of steel
Lexi McNutt is drinking mineral water as she sits outside Spring Café in Aspen. Once a securities attorney in New York, McNutt looks relaxed behind her sunglasses as she eats lunch on this warm, fall afternoon. She talks about her transition from New ...
Aspen Daily News - Sat, 27 Sep 2014 02:22

Doctors tell MS patient that she'll end up in a wheelchair... 6 years later ...
In 2008, Aurora Colello, suddenly went blind in her right eye after experiencing some pain for days. The doctors told her that she had optic neuritis, an inflammation of the optic nerve, and found out that she had 10 lesions in her brain affecting her ...
The Raw Food World News - Wed, 24 Sep 2014 13:26

Multiple Sclerosis: Modern Day MS Fills A Need
Then it hit closer to home. A member of my family was diagnosed with optic neuritis, along with some other worrisome symptoms that are often a sign of MS, so I tried to learn more about the condition. Everything I read was so overwhelming and ...
ChicagoNow (blog) - Wed, 01 Oct 2014 07:37

to-BBB Completes Management Team and Announces Company Name Change ...
LEIDEN, Netherlands, Sep 30, 2014 (BUSINESS WIRE) -- to-BBB, a biopharmaceutical company pioneering treatments for devastating brain diseases, today announced significant additions to complete its new management team as well as changing its name ...
MarketWatch - Mon, 29 Sep 2014 23:00

BofA/Merrill Lynch Reinstates Biogen (BIIB) at Neutral
Nevertheless, we rate BIIB a Neutral as we believe 1) risk/reward heading into the read-out of the anti-LINGO optic neuritis study is balanced, and this study would provide limited read-through for the potential in MS; 2) probability of success for ...
StreetInsider.com (subscription) - Wed, 01 Oct 2014 03:52



Mycophenolate Mofetil Cuts Relapse in MS Variant NMO
A variant of multiple sclerosis, NMOSD is a central nervous system autoimmune inflammatory demyelinating disease that causes severe attacks of optic neuritis and transverse myelitis. The disease course of NMOSD is often more devastating than that of MS ...
Medscape - Mon, 22 Sep 2014 10:26

Dyax Corp. Highlights Recent Progress in Licensing and Funded Research ...
Dyax licensee Biogen Idec Inc. (Biogen) has stated that their Phase 2 clinical trial in acute optic neuritis with anti-LINGO, a fully human monoclonal antibody that targets LINGO-1, is fully enrolled. Biogen has also stated that they expect to disclose ...
MarketWatch - Mon, 22 Sep 2014 04:03


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014